Pelthos Therapeutics PTHS
NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Work In Process (2025 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Work In Process of $16.6 million for Q4 2025.

Pelthos Therapeutics (PTHS) Work In Process (2025 - 2026) Analysis & Trends

Pelthos Therapeutics' Work In Process history runs 1 years deep, the most recent figure standing at $16.6 million for Q4 2025.

  • In Q4 2025, Work In Process changed N/A year-over-year to $16.6 million; the TTM figure through Dec 2025 stood at $16.6 million (changed N/A YoY), while the FY2025 annual figure was $16.6 million, changed N/A from the prior year.
  • Work In Process for Q4 2025 stood at $16.6 million.
  • The five-year high for Work In Process was $16.6 million in Q4 2025, with the low at $16.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Pelthos Therapeutics 96.56 Mn 72.00 Mn 21.23 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 11.81 Mn
Dec 31, 2025 16.56 Mn